Literature DB >> 22233591

Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling.

Chris Timms1, Paul S Thomas, Deborah H Yates.   

Abstract

Gastro-oesophageal reflux disease (GORD) has been implicated in the worsening of several respiratory disorders. Current methods of diagnosis lack accuracy, are invasive and can be costly. Recently, novel methods of analysing lung pathophysiology have been developed including the use of an electronic nose and analysis of components of exhaled breath condensate (EBC). We hypothesised that these methods would distinguish patients with GORD from those without GORD in the common obstructive lung diseases and healthy controls. In a cross-sectional study, exhaled breath was analysed using the Cyranose 320 electronic nose, using principal components and canonical discriminant analyses. EBC pH and pepsin were quantified using a pH meter and an enzyme-linked immunosorbent assay, respectively. A standardized reflux disease questionnaire (RDQ) was used to assess reflux symptoms. The Cyranose 320 distinguished exhaled breath profiles of obstructive lung disease patients without GORD from obstructive lung disease patients with GORD (p = 0.023, accuracy 67.6%), asthmatic patients with reflux from asthmatics without GORD (85%, p = < 0.015, interclass M distance > 2.8), but did not produce as robust a profile for patients with COPD and COPD with GORD (p = 0.047, accuracy 64%). Patients with obstructive lung disease and GORD had significantly higher levels of EBC pepsin (9.81 ± interquartile range (IQR) 4.38 ng ml(-1)) than those without GORD (4.6 ± IQR 6.95 ng ml(-1)), as well as healthy controls (3.44 ± IQR 7.87 ng ml(-1); p = < 0.013). EBC pH was not significantly related to the presence of GORD in any group. The RDQ results correlated significantly with the presence of EBC pepsin. This pilot study has shown that exhaled breath profiling can be used for detecting GORD in obstructive lung diseases. While the electronic nose was useful in asthma, EBC pepsin was more helpful in COPD. In this study, several different confounders could potentially have affected results and larger prospective interventional studies are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22233591     DOI: 10.1088/1752-7155/6/1/016003

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  17 in total

Review 1.  Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.

Authors:  Daniel K Chan; Cadman L Leggett; Kenneth K Wang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 2.  Exhaled breath condensate: an overview.

Authors:  Michael D Davis; Alison Montpetit; John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2012-07-20       Impact factor: 3.479

3.  Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.

Authors:  Laszlo Kunos; Andras Bikov; Zsofia Lazar; Beata Zita Korosi; Palma Benedek; Gyorgy Losonczy; Ildiko Horvath
Journal:  Sleep Breath       Date:  2014-05-20       Impact factor: 2.816

Review 4.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

5.  Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.

Authors:  Andras Bikov; Zsofia Lazar; Nora Gyulai; Marton Szentkereszty; Gyorgy Losonczy; Ildiko Horvath; Gabriella Galffy
Journal:  Lung       Date:  2015-08-11       Impact factor: 2.584

Review 6.  Gastroesophageal reflux disease in COPD: links and risks.

Authors:  Annemarie L Lee; Roger S Goldstein
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-14

Review 7.  Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Márcia Margaret Menezes Pizzichini; Paulo José Zimermann Teixeira; Rosemeri Maurici da Silva; Daisson José Trevisol; Emilio Pizzichini
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

Review 8.  Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath.

Authors:  Alphus D Wilson
Journal:  Metabolites       Date:  2015-03-02

Review 9.  Assessment, origin, and implementation of breath volatile cancer markers.

Authors:  Hossam Haick; Yoav Y Broza; Pawel Mochalski; Vera Ruzsanyi; Anton Amann
Journal:  Chem Soc Rev       Date:  2013-12-04       Impact factor: 54.564

Review 10.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.